ClinicalTrials.Veeva

Menu

Cross Sectional CFAR HIV/COVID-19 Study

University of Miami logo

University of Miami

Status

Completed

Conditions

SARS-CoV Infection
Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04514016
20200802

Details and patient eligibility

About

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Enrollment

64 patients

Sex

All

Ages

3 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children Research Institute (BCRI)
  • Being diagnosed with HIV infection by the time of enrollment
  • At enrollment, 3 to < 26 years

Exclusion criteria

  • Patient will be excluded from the study if any of the following are identified:
  • Patients under legal age and in the State's custody
  • Participant or legal guardian unable to sign Informed Consent forms
  • Participant unable to complete study visits

Trial design

64 participants in 2 patient groups

HIV positive participants with positive COVID-19 results
Description:
Participants in this group will have a RT-PCR and Coronavirus Disease (COVID) -19 specific antibody testing at baseline, 1 month and 3 month visits.
HIV positive participants with negative COVID-19 results
Description:
Participants in this group will have a RT-PCR and COVID-19 specific antibody testing at baseline only.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems